基于超声的脂肪分数用于检测肝脂肪变性和定量肝脏脂肪含量:以肝活检为参考标准
回顾性分析2022年8月至2023年11月前瞻性招募的疑似代谢相关脂肪性肝病(MASLD)参与者264例,以肝活检为参考标准,评估组织衰减成像(TAI)、组织散射分布成像(TSI)和超声脂肪分数(USFF)的诊断性能。USFF与肝脂肪变性分级呈良好正相关(r=0.62),TAI、TSI和USFF在检测轻度及以上肝脂肪变性时AUC较高(指数集0.95-0.98,验证集0.92-0.96),但对所有分级(S0-S3)的多分类诊断性能仅为中等至欠佳。
要点
- USFF与肝脂肪变性分级正相关(r=0.62),优于TAI(r=0.57)和TSI(r=0.56)。
- TAI、TSI和USFF检测轻度及以上肝脂肪变性AUC高(指数集0.95-0.98,验证集0.92-0.96)。
- 多分类诊断所有肝脂肪变性分级(S0-S3)性能仅中等至欠佳(VUS 0.18-0.51)。
核心结论
- USFF与组织病理学肝脂肪变性分级呈良好正相关;TAI、TSI和USFF可能是检测MASLD中轻度肝脂肪变性的潜在定量诊断工具,但需在更大且更均衡的队列中进一步验证。
研究设计与样本
- 回顾性分析前瞻性招募的疑似MASLD参与者,2022年8月至2023年11月,共264例(227例活检确诊MASLD,37例肝活检正常),以肝活检为参考标准,测量TAI、TSI和USFF。
诊断标准与关键数值
- USFF与肝脂肪变性正相关(总体集rUSFF=0.62,rTAI=0.57,rTSI=0.56;均p<0.001);多分类ROC分析TAI、TSI和USFF对所有肝脂肪变性(S0-S3)诊断性能指数集VUS 0.21-0.51、验证集VUS 0.18-0.34;二分类ROC检测轻度及以上肝脂肪变性指数集AUC 0.95-0.98、验证集AUC 0.92-0.96。
临床应用与阅片要点
- TAI、TSI和USFF可能是检测MASLD中轻度肝脂肪变性的潜在无创工具,并可用于大规模随访。
局限性
- 需在更大且更均衡的队列中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To analyze the diagnostic performance of tissue attenuation imaging (TAI), tissue scatter-distribution imaging (TSI) and ultrasound-based fat fraction (USFF) in suspected metabolic-associated fatty liver disease (MASLD), using histopathological hepatic steatosis as the reference standard.
MATERIALS AND METHODS: This was a retrospective analysis of prospectively recruited participants with suspected MASLD from August 2022 to November 2023. TAI, TSI and USFF were measured. Spearman correlation analysis was used to evaluate the correlation of TAI, TSI and USFF with hepatic steatosis. The diagnostic performance for detecting hepatic steatosis was evaluated by multiclass or binary receiver operating characteristic (ROC) curves.
RESULTS: A total of 264 participants were enrolled, including 227 with biopsy-confirmed MASLD and 37 with normal liver biopsy results. Compared with TAI and TSI, USFF had a better positive correlation with hepatic steatosis in the overall set (rUSFF = 0.62, rTAI = 0.57, rTSI = 0.56; all p < 0.001). Multiclass ROC analysis indicated TAI, TSI and USFF exhibited only modest to suboptimal diagnostic performance for all hepatic steatosis (S0-S3) in index (volume under surface (VUS) 0.21-0.51) and validation set (VUS 0.18-0.34). However, binary ROC curves revealed TAI, TSI and USFF yielded the highest AUCs in detecting mild or greater hepatic steatosis in index (AUC 0.95-0.98) and validation set (AUC 0.92-0.96).
CONCLUSIONS: USFF has a good correlation with histopathological hepatic steatosis grade. TAI, TSI and USFF might be potential quantitative diagnostic tools for detecting mild hepatic steatosis in MASLD, though further validation in larger and more balanced cohorts is needed.
KEY POINTS: Question How is the diagnostic performance of quantitative ultrasound parameters in suspected metabolic dysfunction-associated steatotic liver disease using liver biopsy as the reference standard? Findings Tissue attenuation imaging, tissue scatter-distribution imaging and ultrasound-based fat fraction show promising diagnostic potential for mild hepatic steatosis in metabolic dysfunction-associated steatotic liver disease. Clinical relevance Tissue attenuation imaging, tissue scatter-distribution imaging, and ultrasound-based fat fraction might be potential noninvasive tools for detecting mild hepatic steatosis and conducting large-scale follow-ups in metabolic dysfunction-associated steatotic liver disease.
引用
- Ji C, He Y, Fan Y, et al. Ultrasound-based fat fraction for detection of hepatic steatosis and quantification of liver fat content using liver biopsy as the reference standard. Eur Radiol. 2025. PMID: 41198864. doi:10.1007/s00330-025-12117-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。